Location History:
- Chicago, IL (US) (2008)
- Madison, WI (US) (1997 - 2009)
Company Filing History:
Years Active: 1997-2009
Title: Innovations in Breast Cancer Treatment by Eric A. Ariazi
Introduction
Eric A. Ariazi is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of breast cancer research, holding a total of 3 patents. His work focuses on utilizing estrogen-related receptors as biomarkers and therapeutic targets for breast cancer treatment.
Latest Patents
Ariazi's latest patents include methods for using estrogen-related receptor alpha (ERRα) status to determine prognosis, treatment strategy, and predisposition to breast cancer. This invention highlights that ERRα serves as a breast cancer biomarker, indicating poor prognosis when present at high levels. Additionally, it provides insights into treatment choices for patients by analyzing ERRα expression alongside the status of ERα and ErbB2. Furthermore, his work on ERRα suggests that modulating its activity can be a viable treatment strategy for breast cancer.
Another significant patent involves the use of estrogen-related receptor gamma (ERRγ) status to determine prognosis and treatment strategies for breast cancer. This invention establishes ERRγ as both a biomarker and a treatment target. A high level of ERRγ in breast cancer cells indicates a good prognosis, while its presence in suspicious breast tissue can signal cancer. Analyzing ERRγ status can aid in making informed treatment decisions, and decreasing ERRγ activity may also serve as a therapeutic approach.
Career Highlights
Eric A. Ariazi is affiliated with the Wisconsin Alumni Research Foundation, where he continues to advance research in breast cancer treatment. His innovative approaches have the potential to significantly impact patient care and treatment outcomes.
Collaborations
Ariazi has collaborated with esteemed colleagues such as Janet E. Mertz and Michael N. Gould, contributing to the advancement of breast cancer research through shared expertise and innovative ideas.
Conclusion
Eric A. Ariazi's work in breast cancer research exemplifies the importance of innovation in medical science. His patents on estrogen-related receptors provide valuable insights into prognosis and treatment strategies, potentially improving outcomes for breast cancer patients.